Inclusion Criteria:
  1. Provision of signed and dated informed consent form
  2. Stated willingness to comply with all study procedures and availability for the duration of the study
  3. Men and women â‰¥ 18 year-old
  4. Diagnosed with moderate to severe mitral stenosis who have a history of AF of any duration documented by any electrical tracing within the prior 12 months and for which anticoagulation is indicated and planned for the duration of the study.
  5. Ability to take oral medication and be willing to adhere to the rivaroxaban regimen
Exclusion Criteria:
  1. Left atrial clot
  2. Severe renal dysfunction (creatinine clearance [CrCl] <15 mL/min), subjects with
  3. A condition associated with a high risk of bleeding
  4. Allergic to rivaroxabn/warfarin